AI-supported modified risk staging for multiple myeloma cancer useful in real-world scenario

INTRODUCTION: : An efficient readily employable risk prognostication method is desirable for MM in settings where genomics tests cannot be performed owing to geographical/economical constraints. In this work, a new Modified Risk Staging (MRS) has been proposed for newly diagnosed Multiple Myeloma (N...

Descripción completa

Detalles Bibliográficos
Autores principales: Farswan, Akanksha, Gupta, Anubha, Gupta, Ritu, Hazra, Saswati, Khan, Sadaf, Kumar, Lalit, Sharma, Atul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278429/
https://www.ncbi.nlm.nih.gov/pubmed/34247136
http://dx.doi.org/10.1016/j.tranon.2021.101157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278429/
https://www.ncbi.nlm.nih.gov/pubmed/34247136
http://dx.doi.org/10.1016/j.tranon.2021.101157

Ejemplares similares